PCR Investment Fund IV, LLC — Form D/A
PCR Investment Fund IV, LLC of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2022-01-06. The offering totals $57.8M, of which $57.8M was reported sold. Industry: Commercial.
Offering
- Filed: 2022-01-06
- Form: D/A
- Accession: 0001832283-22-000001
- Industry: Commercial
- Exemptions: 06b
- Total offering: $57.8M
- Amount sold: $57.8M
- Minimum investment: $100K
- Investors: 317
- Date of first sale: 2021-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-381375
Issuer
- Name: PCR Investment Fund IV, LLC
- CIK: 0001832283
- Entity type: Limited Liability Company
- Jurisdiction: TEXAS
- Incorporated: 2020
- Address: 1360 POST OAK BLVD, SUITE 1900, HOUSTON, TX, 77056
- Phone: 7139854610
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| n/a PCR Investment Company, LLC | Director | HOUSTON, TX |
| n/a PCR Investment Company, LLC | Executive Officer | HOUSTON, TX |
Other filings by this issuer (1)
More